Colon, rectal, and anal cancer management

Oncology: An Evidence-Based Approach

Volumn , Issue , 2006, Pages 711-739

  Skibber, John M ^a   Eng, Cathy ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892357110     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-31056-8_42     Document Type: Chapter

References (367)

1. Konishi F, Morson BC. Pathology of colorectal adenomas: a colonoscopic survey. J Clin Pathol 1982;35(8):830-841.
2. Winawer SJ, Zauber AG, O'Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 1993;328(13):901-906.
3. Morson BC, Konishi F. Contribution of the pathologist to the radiology and management of colorectal polyps. Gastrointest Radiol 1982;7(3):275-281.
4. Gillespie PE, Chambers TJ, Chan KW, Doronzo F, Morson BC, Williams CB. Colonic adenomas-a colonoscopy survey. Gut 1979;3:240-245.
5. Shirai M, Nakamura T, Matsuura A, Ito Y, Kobayashi S. Safer colonoscopic polypectomy with local submucosal injection of hypertonic saline-epinephrine solution. Am J Gastroenterol 1994;89(3):334-338.
6. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329(27):1977-1981.
7. Waye JD, Lewis BS, Frankel A, Geller SA. Small colon polyps. Am J Gastroenterol 1988;83(2):120-122.
8. Binmoeller KF, Bohnacker S, Seifert H, Thonke F, Valdeyar H, Soehendra N. Endoscopic snare excision of "giant" colorectal polyps. Gastrointest Endosc 1996;43(3):183-188.
9. Cohen LB, Waye JD. Treatment of colonic polyps-practical considerations. Clin Gastroenterol 1986;15(2):359-376.
10. Pello MJ. Transanal excision of large sessile villous adenomas using an endorectal traction flap. Surg Gynecol Obstet 1987; 164(3):280-282.
11. Fenoglio CM, Kaye GI, Lane N. Distribution of human colonic lymphatics in normal, hyperplastic, and adenomatous tissue. Its relationship to metastasis from small carcinomas in pedunculated adenomas, with two case reports. Gastroenterology 1973; 64(1):51-66.
12. Cooper HS. Surgical pathology of endoscopically removed malignant polyps of the colon and rectum. Am J Surg Pathol 1983;7(7):613-623.
13. Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 2000;95(11):3053-3063.
14. Gordon MS, Cohen AM. Management of invasive carcinoma in pedunculated colorectal polyps. Oncology (Huntingt) 1989; 3(7):99-104; discussion 104-105.
15. Fucini C, Wolff BG, Spencer RJ. An appraisal of endoscopic removal of malignant colonic polyps. Mayo Clin Proc 1986; 61(2):123-126.
16. Williams CB, Whiteway JE, Jass JR. Practical aspects of endoscopic management of malignant polyps. Endoscopy 1987; 19(suppl 1):31-37.
17. Lipper S, Kahn LB, Ackerman LV. The significance of microscopic invasive cancer in endoscopically removed polyps of the large bowel. A clinicopathologic study of 51 cases. Cancer (Phila) 1983;52(9):1691-1699.
18. Morson BC, Whiteway JE, Jones EA, Macrae FA, Williams CB. Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut 1984;25(5):437-444.
19. Minsky BD, Mies C, Rich TA, Recht A, Chaffey JT. Potentially curative surgery of colon cancer: the influence of blood vessel invasion. J Clin Oncol 1988;6(1):119-127.
20. Minsky B, Mies C. The clinical significance of vascular invasion in colorectal cancer. Dis Colon Rectum 1989;32(9):794-803.
21. Shirouzu K, Isomoto H, Kakegawa T, Morimatsu M. A prospective clinicopathologic study of venous invasion in colorectal cancer. Am J Surg 1991;162(3):216-222.
22. Muller S, Chesner IM, Egan MJ, et al. Significance of venous and lymphatic invasion in malignant polyps of the colon and rectum. Gut 1989;30(10):1385-1391.
23. Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology 1985;89(2):328-336.
24. Netzer P, Forster C, Biral R, et al. Risk factor assessment of endoscopically removed malignant colorectal polyps. Gut 1998;43(5):669-674.
25. Wilcox GM, Beck JR. Early invasive cancer in adenomatous colonic polyps ("malignant polyps"). Evaluation of the therapeutic options by decision analysis. Gastroenterology 1987;92(5 pt 1):1159-1168.
26. Fitzgerald SD, Longo WE, Daniel GL, Vernava AM III. Advanced colorectal neoplasia in the high-risk elderly patient: is surgical resection justified? Dis Colon Rectum 1993;36(2):161-166.
27. Christie JP. Polypectomy or colectomy? Management of 106 consecutively encountered colorectal polyps. Am Surg 1988; 54(2):93-99.
28. Eckardt VF, Fuchs M, Kanzler G, Remmele W, Stienen U. Follow-up of patients with colonic polyps containing severe atypia and invasive carcinoma. Compliance, recurrence, and survival. Cancer (Phila) 1988;61(12):2552-2557.
29. Coutsoftides T, Sivak MV Jr, Benjamin SP, Jagelman D. Colonoscopy and the management of polyps containing invasive carcinoma. Ann Surg 1978;188(5):638-641.
30. Volk EE, Goldblum JR, Petras RE, Carey WD, Fazio VW. Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology 1995;109(6):1801-1807.
31. Coverlizza S, Risio M, Ferrari A, Fenoglio-Preiser CM, Rossini FP. Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential. Cancer (Phila) 1989;64(9):1937-1947.
32. Greenburg AG, Saik RP, Coyle JJ, Peskin GW. Mortality and gastrointestinal surgery in the aged: elective vs. emergency procedures. Arch Surg 1981;116(6):788-791.
33. Limpert P, Longo WE, Kelemen PR, et al. Colon and rectal cancer in the elderly. High incidence of asymptomatic disease, less surgical emergencies, and a favorable short-term outcome. Crit Rev Oncol Hematol 2003;48(2):159-163.
34. Shatz BA, Weinstock LB, Swanson PE, Thyssen EP. Long-term safety of India ink tattoos in the colon. Gastrointest Endosc 1997;45(2):153-156.
35. Kuramoto S, Ihara O, Sakai S, Tsuchiya T, Oohara T. Intraoperative colonoscopy in the detection of nonpalpable colonic lesions: how to identify the affected bowel segment. Surg Endosc 1988;2(2):76-80.
36. Whitlow C, Gathright JB Jr, Hebert SJ, et al. Long-term survival after treatment of malignant colonic polyps. Dis Colon Rectum 1997;40(8):929-934.
37. Markowitz AJ, Winawer SJ. Management of colorectal polyps. CA Cancer J Clin 1997;47(2):93-112.
38. Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 1999;6(7):651-657.
39. Winawer SJ, Zauber AG, Gerdes H, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med 1996;334(2): 82-87.
40. Ekelund GR, Pihl B. Multiple carcinomas of the colon and rectum. Cancer (Phila) 1974;33(6):1630-1634.
41. Pagana TJ, Ledesma EJ, Mittelman A, Nava HR. The use of colonoscopy in the study of synchronous colorectal neoplasms. Cancer (Phila) 1984;53(2):356-359.
42. Askew A, Ward M, Cowen A. The influence of colonoscopy on the operative management of colorectal cancer. Med J Aust 1986;145(6):254-255.
43. Arenas RB, Fichera A, Mhoon D, Michelassi F. Incidence and therapeutic implications of synchronous colonic pathology in colorectal adenocarcinoma. Surgery (St. Louis) 1997;122(4):706-709; discussion 709-710.
44. Barrier A, Houry S, Huguier M. The appropriate use of colonoscopy in the curative management of colorectal cancer. Int J Colorectal Dis 1998;13(2):93-98.
45. Chapuis P, Kos S, Bokey L, Dent O, Newland R, Hinder J. How useful is pre-operative computerized tomography scanning in staging rectal cancer? Aust N Z J Surg 1989;59(1):31-34.
46. Isbister WH, al-Sanea O. The utility of pre-operative abdominal computerized tomography scanning in colorectal surgery. J R Coll Surg (Edinb) 1996;41(4):232-234.
47. Kronawitter U, Kemeny NE, Heelan R, Fata F, Fong Y. Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer (Phila) 1999;86(2):229-235.
48. Lewi H, Blumgart LH, Carter DC, et al. Pre-operative carcinoembryonic antigen and survival in patients with colorectal cancer. Br J Surg 1984;71(3):206-208.
49. Lunde OC, Havig O. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum. Acta Chir Scand 1982;148(2):189-193.
50. Wanebo HJ, Rao B, Pinsky CM, et al. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 1978;299(9):448-451.
51. Wang WS, Lin JK, Chiou TJ, et al. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience. Jpn J Clin Oncol 2000; 30(1):12-16.
52. Heriot AG, Hicks RJ, Drummond EG, et al. Does positron emission tomography change management in primary rectal cancer? A prospective assessment. Dis Colon Rectum 2004;47(4):451-458.
53. Abdel-Nabi H, Doerr RJ, Lamonica DM, et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 1998;206(3):755-760.
54. Beart RW, Steele GD Jr, Menck HR, Chmiel JS, Ocwieja KE, Winchester DP. Management and survival of patients with adenocarcinoma of the colon and rectum: a national survey of the Commission on Cancer. J Am Coll Surg 1995;181(3):225-236.
55. Charnley RM, Morris DL, Dennison AR, Amar SS, Hardcastle JD. Detection of colorectal liver metastases using intraoperative ultrasonography. Br J Surg 1991;78(1):45-48.
56. Rafaelsen SR, Kronborg O, Larsen C, Fenger C. Intraoperative ultrasonography in detection of hepatic metastases from colorectal cancer. Dis Colon Rectum 1995;38(4):355-360.
57. Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001;93(8):583-596.
58. Bruch HP, Schwandner O, Schiedeck TH, Roblick UJ. Actual standards and controversies on operative technique and lymphnode dissection in colorectal cancer. Langenbecks Arch Surg 1999;384(2):167-175.
59. Fazio VW, Tjandra JJ. Primary therapy of carcinoma of the large bowel. World J Surg 1991;15(5):568-575.
60. Morikawa E, Yasutomi M, Shindou K, et al. Distribution of metastatic lymph nodes in colorectal cancer by the modified clearing method. Dis Colon Rectum 1994;37(3):219-223.
61. Devereux DF, Deckers PJ. Contributions of pathologic margins and Dukes' stage to local recurrence in colorectal carcinoma. Am J Surg 1985;149(3):323-326.
62. Tagliacozzo S, Tocchi A. Extended mesenteric excision in right hemicolectomy for carcinoma of the colon. Int J Colorectal Dis 1997;12(5):272-275.
63. Wu JS, Paul P, McGannon EA, Church JM. APC genotype, polyp number, and surgical options in familial adenomatous polyposis. Ann Surg 1998;227(1):57-62.
64. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264(11):1444-1450.
65. Scott KW, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 1989;76(11):1165-1167.
66. Enker WE, Laffer UT, Block GE. Enhanced survival of patients with colon and rectal cancer is based upon wide anatomic resection. Ann Surg 1979;190(3):350-360.
67. Toyota S, Ohta H, Anazawa S. Rationale for extent of lymph node dissection for right colon cancer. Dis Colon Rectum 1995; 38(7):705-711.
68. Malassagne B, Valleur P, Serra J, et al. Relationship of apical lymph node involvement to survival in resected colon carcinoma. Dis Colon Rectum 1993;36(7):645-653.
69. Slanetz CA Jr, Grimson R. Effect of high and intermediate ligation on survival and recurrence rates following curative resection of colorectal cancer. Dis Colon Rectum 1997;40(10): 1205-1218; discussion 1218-1219.
70. Rouffet F, Hay JM, Vacher B, et al. Curative resection for left colonic carcinoma: hemicolectomy vs. segmental colectomy. A prospective, controlled, multicenter trial. French Association for Surgical Research. Dis Colon Rectum 1994;37(7):651-659.
71. Laurie J, Moertel C, Flemming T, et al. Surgical adjuvant therapy of poor prognosis colorectal cancer with levamisole alone or combined levamisol and 5-fluorouracil: a North Central Cancer Treatment Group and Mayo Clinic Study. Proc Am Soc Clin Oncol 1986;5(81):81 (abstract).
72. Cohen AM, Tremiterra S, Candela F, Thaler HT, Sigurdson ER. Prognosis of node-positive colon cancer. Cancer (Phila) 1991; 67(7):1859-1861.
73. Brown HG, Luckasevic TM, Medich DS, Celebrezze JP, Jones SM. Efficacy of manual dissection of lymph nodes in colon cancer resections. Mod Pathol 2004;17(4):402-406.
74. Gall FP, Tonak J, Altendorf A. Multivisceral resections in colorectal cancer. Dis Colon Rectum 1987;30(5):337-341.
75. Taylor WE, Donohue JH, Gunderson LL, et al. The Mayo Clinic experience with multimodality treatment of locally advanced or recurrent colon cancer. Ann Surg Oncol 2002;9(2):177-185.
76. Sales JP, Wind P, Douard R, Cugnenc PH, Loric S. Blood dissemination of colonic epithelial cells during no-touch surgery for rectosigmoid cancer. Lancet 1999;354(9176):392.
77. Wiggers T, Jeekel J, Arends JW, et al. No-touch isolation technique in colon cancer: a controlled prospective trial. Br J Surg 1988;75(5):409-415.
78. Gordon NL, Dawson AA, Bennett B, Innes G, Eremin O, Jones PF. Outcome in colorectal adenocarcinoma: two seven-year studies of a population. BMJ 1993;307(6906):707-710.
79. Read TE, Mutch MG, Chang BW, et al. Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon. J Am Coll Surg 2002;195(1):33-40.
80. Schrag D, Panageas KS, Riedel E, et al. Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol 2003;83(2):68-78; discussion 78-79.
81. Ota DM. Laparoscopic resection for colon cancer: a favorable view. Important Adv Oncol 1996:227-229.
82. Schwenk W, Bohm B, Witt C, Junghans T, Grundel K, Muller JM. Pulmonary function following laparoscopic or conventional colorectal resection: a randomized controlled evaluation. Arch Surg 1999;134(1):6-12; discussion 13.
83. Fleshman JW, Nelson H, Peters WR, et al. Early results of laparoscopic surgery for colorectal cancer. Retrospective analysis of 372 patients treated by Clinical Outcomes of Surgical Therapy (COST) Study Group. Dis Colon Rectum 1996;39(suppl 10): S53-S58.
84. Kockerling F, Reymond MA, Schneider C, et al. Prospective multicenter study of the quality of oncologic resections in patients undergoing laparoscopic colorectal surgery for cancer. The Laparoscopic Colorectal Surgery Study Group. Dis Colon Rectum 1998;41(8):963-970.
85. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 2004;350(20):2050-2059.
86. Lacy AM, Garcia-Valdecasas JC, Delgado S, et al. Laparoscopyassisted colectomy versus open colectomy for treatment of nonmetastatic colon cancer: a randomised trial. Lancet 2002; 359(9325):2224-2229.
87. Huang PP, Weber TK, Mendoza C, Rodriguez-Bigas MA, Petrelli NJ. Long-term survival in patients with ovarian metastases from colorectal carcinoma. Ann Surg Oncol 1998;5(8):695-698.
88. Sielezneff I, Salle E, Antoine K, Thirion X, Brunet C, Sastre B. Simultaneous bilateral oophorectomy does not improve prognosis of postmenopausal women undergoing colorectal resection for cancer. Dis Colon Rectum 1997;40(11):1299-1302.
89. Nyam DC, Leong AF, Ho YH, Seow-Choen F. Comparison between segmental left and extended right colectomies for obstructing left-sided colonic carcinomas. Dis Colon Rectum 1996;39(9):1000-1003.
90. Young-Fadok TM, Wolff BG, Nivatvongs S, Metzger PP, Ilstrup DM. Prophylactic oophorectomy in colorectal carcinoma: preliminary results of a randomized, prospective trial. Dis Colon Rectum 1998;41(3):277-283; discussion 283-285.
91. Mulcahy HE, Toner M, Patchett SE, Daly L, O'Donoghue DP. Identifying stage B colorectal cancer patients at high risk of tumor recurrence and death. Dis Colon Rectum 1997;40(3): 326-331.
92. Joseph NE, Sigurdson ER, Hanlon AL, et al. Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol 2003; 10(3):213-218.
93. Tepper JE, O'Connell MJ, Niedzwiecki D, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 2001;19(1):157-163.
94. Mainprize KS, Kulacoglu H, Hewavisinthe J, Savage A, Mortensen N, Warren BF. How many lymph nodes to stage colorectal carcinoma? J Clin Pathol 1998;51(2):165-166.
95. Oberg A, Stenling R, Tavelin B, Lindmark G. Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer? Dis Colon Rectum 1998;41(10): 1244-1249.
96. Yasuda K, Adachi Y, Shiraishi N, Yamaguchi K, Hirabayashi Y, Kitano S. Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol 2001; 8(4):300-304.
97. Finan PJ, Ritchie JK, Hawley PR. Synchronous and "early" metachronous carcinomas of the colon and rectum. Br J Surg 1987;74(10):945-947.
98. Isler JT, Brown PC, Lewis FG, Billingham RP. The role of preoperative colonoscopy in colorectal cancer. Dis Colon Rectum 1987;30(6):435-439.
99. Tate JJ, Rawlinson J, Royle GT, Brunton FJ, Taylor I. Pre-operative or postoperative colonic examination for synchronous lesions in colorectal cancer. Br J Surg 1988;75(10):1016-1018.
100. Passman MA, Pommier RF, Vetto JT. Synchronous colon primaries have the same prognosis as solitary colon cancers. Dis Colon Rectum 1996;39(3):329-334.
101. Koperna T, Kisser M, Schulz F. Emergency surgery for colon cancer in the aged. Arch Surg 1997;132(9):1032-1037.
102. Poon RT, Law WL, Chu KW, Wong J. Emergency resection and primary anastomosis for left-sided obstructing colorectal carcinoma in the elderly. Br J Surg 1998;85(11):1539-1542.
103. Single-stage treatment for malignant left-sided colonic obstruction: a prospective randomized clinical trial comparing subtotal colectomy with segmental resection following intraoperative irrigation. The SCOTIA Study Group. Subtotal Colectomy versus On-table Irrigation and Anastomosis. Br J Surg 1995; 82(12):1622-1627.
104. Carraro PG, Segala M, Orlotti C, Tiberio G. Outcome of largebowel perforation in patients with colorectal cancer. Dis Colon Rectum 1998;41(11):1421-1426.
105. Willett C, Tepper JE, Cohen A, Orlow E, Welch C. Obstructive and perforative colonic carcinoma: patterns of failure. J Clin Oncol 1985;3(3):379-384.
106. Estes NC, Giri S, Fabian C. Patterns of recurrence for advanced colon cancer modified by whole abdominal radiation and chemotherapy. Am Surg 1996;62(7):546-549; discussion 549-550.
107. Duttenhaver JR, Hoskins RB, Gunderson LL, Tepper JE. Adjuvant postoperative radiation therapy in the management of adenocarcinoma of the colon. Cancer (Phila) 1986;57(5):955-963.
108. Willett CG, Tepper JE, Skates SJ, Wood WC, Orlow EC, Duttenhaver JR. Adjuvant postoperative radiation therapy for colonic carcinoma. Ann Surg 1987;206(6):694-698.
109. Willett CG, Fung CY, Kaufman DS, Efird J, Shellito PC. Postoperative radiation therapy for high-risk colon carcinoma. J Clin Oncol 1993;11(6):1112-1117.
110. Amos EH, Mendenhall WM, McCarty PJ, et al. Postoperative radiotherapy for locally advanced colon cancer. Ann Surg Oncol 1996;3(5):431-436.
111. Willett CG, Goldberg S, Shellito PC, et al. Does postoperative irradiation play a role in the adjuvant therapy of stage T4 colon cancer? Cancer J Sci Am 1999;5(4):242-247.
112. Ben-Josef E, Court WS. Whole abdominal radiotherapy and concomitant 5-fluorouracil as adjuvant therapy in advanced colon cancer. Dis Colon Rectum 1995;38(10):1088-1092.
113. Fabian C, Giri S, Estes N, et al. Adjuvant continuous infusion 5-FU, whole-abdominal radiation, and tumor bed boost in highrisk stage III colon carcinoma: a Southwest Oncology Group Pilot study. Int J Radiat Oncol Biol Phys 1995;32(2):457-464.
114. Schild SE, Gunderson LL, Haddock MG, Wong WW, Nelson H. The treatment of locally advanced colon cancer. Int J Radiat Oncol Biol Phys 1997;37(1):51-58.
115. Pezner RD, Chu DZ, Wagman LD, Vora N, Wong JY, Shibata SI. Resection with external beam and intraoperative radiotherapy for recurrent colon cancer. Arch Surg 1999;134(1):63-67.
116. Midgley R, Kerr D. Colorectal cancer. Lancet 1999;353(9150): 391-399.
117. Buyse M, Zeleniuch-Jacquotte A, Chalmers TC. Adjuvant therapy of colorectal cancer. Why we still don't know. JAMA 1988;259(24):3571-3578.
118. Wolmark N, Fisher B, Rockette H, et al. Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. J Natl Cancer Inst 1988;80(1):30-36.
119. Saltz LB, Minsky B. Adjuvant therapy of cancers of the colon and rectum. Surg Clin N Am 2002;82(5):1035-1058.
120. Wolmark N, Rockette H, Fisher B, et al. The benefit of leucovorin- modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 1993; 11(10):1879-1887.
121. AbdAlla EE, Blair GE, Jones RA, Sue-Ling HM, Johnston D. Mechanism of synergy of levamisole and fluorouracil: induction of human leukocyte antigen class I in a colorectal cancer cell line. J Natl Cancer Inst 1995;87(7):489-496.
122. Laurie JA, Moertel CG, Fleming TR, et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol 1989;7(10):1447-1456.
123. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322(6):352-358.
124. Moertel CG, Fleming TR, Macdonald JS, et al. Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol 1995;13(12):2936-2943.
125. Piedbois P. Survival benefit of 5-FU/LV over 5-FU bolus in patients with advanced colorectal cancer: an updated metaanalysis based on 2, 751 patients. Proc Annu Meet Am Soc Clin Oncol 2003;22:a1180.
126. O'Connell MJ, Laurie JA, Kahn M, et al. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol 1998;16(1):295-300.
127. Wolmark N, Rockette H, Mamounas E, et al. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04. J Clin Oncol 1999;17(11):3553-3559.
128. Haller D, Catalano P, Macdonald J. Fluorouracil (FU), leucovorin (LV), and levamisole (LeV) adjuvant therapy for colon cancer: 5- year final report of INT-0089. Proc Annu Meet Am Soc Clin Oncol 1998;17:a982.
129. Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 28 2000;343(13):905-914.
130. Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000;355(9209):1041-1047.
131. de Gramont A, Bosset JF, Milan C, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J Clin Oncol 1997;15(2):808-815.
132. Pflzer U.S. Medical Information, Camptosar as adjuvant therapy in colorectal cancer, Sept. 8, 2003.
133. Degramont A, Banzi M, Navarro M. Oxaliplatin/5-FU/LV in adjuvant colon cancer: results of the international MOSAIC trial. Proc Annu Meet Am Soc Clin Oncol 2003;22:a1015.
134. Becouarn Y, Rougier P. Clinical efficacy of oxaliplatin monotherapy: phase II trials in advanced colorectal cancer. Semin Oncol 1998;25(2 suppl 5):23-31.
135. de Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000;18(16):2938-2947.
136. Becouarn Y, Gamelin E, Coudert B, et al. Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients. J Clin Oncol 15 2001;19(22): 4195-4201.
137. Rothenberg ML, Oza AM, Bigelow RH, et al. Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J Clin Oncol 2003;21(11):2059-2069.
138. Goldberg R, Morton R, Sargent D. N9741: oxaliplatin or CPT-11+5-FU/LV or oxaliplatin + CPT-11 in advanced colorectal cancer: updated efficacy and quality of life data from an Intergroup study. Proc Annu Meet Am Soc Clin Oncol 2003;22:a1009.
139. Gramont Ad, Banzi M, Navarro M. Oxaliplatin/5-FU/LV in adjuvant colon cancer: results of the international randomized phase III "MOSAIC" trial. Proc Annu Meet Am Soc Clin Oncol 2003; 22:a1015.
140. Willett C, Tepper JE, Cohen A, Orlow E, Welch C, Donaldson G. Local failure following curative resection of colonic adenocarcinoma. Int J Radiat Oncol Biol Phys 1984;10(5):645-651.
141. Cascinu S, Georgoulias V, Kerr D, Maughan T, Labianca R, Ychou M. Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors. Ann Oncol 2003;14(suppl 2):ii25-ii29.
142. Watanabe T, Wu TT, Catalano PJ, et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 2001;344(16):1196- 1206.
143. Ogunbiyi OA, Goodfellow PJ, Herfarth K, et al. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol 1998;16(2):427-433.
144. Moertel CG, Fleming TR, Macdonald JS, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 1995;122(5):321-326.
145. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. J Clin Oncol 1999; 17(5):1356-1363.
146. Mamounas E, Wieand S, Wolmark N, et al. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04). J Clin Oncol 1999;17(5):1349-1355.
147. Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000;342(2):69-77.
148. Lynch HT, Drouhard T, Vasen HF, et al. Genetic counseling in a Navajo hereditary nonpolyposis colorectal cancer kindred. Cancer (Phila) 1996;77(1):30-35.
149. Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatelliteinstability status as a predictor of benefit from fluorouracilbased adjuvant chemotherapy for colon cancer. N Engl J Med 2003;349(3):247-257.
150. Elsaleh H, Joseph D, Grieu F, Zeps N, Spry N, Iacopetta B. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 2000; 355(9217):1745-1750.
151. Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124(7):979-994.
152. Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 1991;324(12):808-815.
153. Tveit KM, Guldvog I, Hagen S, et al. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5- fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Br J Surg 1997;84(8):1130-1135.
154. Wolmark N, Wieand HS, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 2000; 92(5):388-396.
155. Olson RM, Perencevich NP, Malcolm AW, Chaffey JT, Wilson RE. Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum. Cancer (Phila) 1980; 45(12):2969-2974.
156. Dehni N, McFadden N, McNamara DA, Guiguet M, Tiret E, Parc R. Oncologic results following abdominoperineal resection for adenocarcinoma of the low rectum. Dis Colon Rectum 2003;46(7):867-874; discussion 874.
157. Tocchi A, Mazzoni G, Lepre L, et al. Total mesorectal excision and low rectal anastomosis for the treatment of rectal cancer and prevention of pelvic recurrences. Arch Surg 2001;136(2): 216-220.
158. Merchant NB, Guillem JG, Paty PB, et al. T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy. J Gastrointest Surg 1999;3(6):642-647.
159. Nakagoe T, Ishikawa H, Sawai T, et al. Survival and recurrence after a sphincter-saving resection and abdominoperineal resection for adenocarcinoma of the rectum at or below the peritoneal reflection: a multivariate analysis. Surg Today 2004;34(1):32-39.
160. Nakagoe T, Sawai T, Tsuji T, et al. Local rectal tumor resection results: gasless, video-endoscopic transanal excision versus the conventional posterior approach. World J Surg 2003;27(2): 197-202.
161. Neary P, Makin GB, White TJ, et al. Transanal endoscopic microsurgery: a viable operative alternative in selected patients with rectal lesions. Ann Surg Oncol 2003;10(9):1106-1111.
162. Sutton CD, Marshall LJ, White SA, Flint N, Berry DP, Kelly MJ. Ten-year experience of endoscopic transanal resection. Ann Surg 2002;235(3):355-362.
163. Bouvet M, Milas M, Giacco GG, Cleary KR, Janjan NA, Skibber JM. Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum. Ann Surg Oncol 1999;6(1):26-32.
164. Willett CG, Tepper JE, Donnelly S, et al. Patterns of failure following local excision and local excision and postoperative radiation therapy for invasive rectal adenocarcinoma. J Clin Oncol 1989;7(8):1003-1008.
165. Harewood GC, Wiersema MJ, Nelson H, et al. A prospective, blinded assessment of the impact of preoperative staging on the management of rectal cancer. Gastroenterology 2002;123(1): 24-32.
166. Morson BC. Factors influencing the prognosis of early cancer of the rectum. Proc R Soc Med 1966;59(7):607-608.
167. Minsky BD, Rich T, Recht A, Harvey W, Mies C. Selection criteria for local excision with or without adjuvant radiation therapy for rectal cancer. Cancer (Phila) 1989;63(7):1421-1429.
168. Graham RA, Garnsey L, Jessup JM. Local excision of rectal carcinoma. Am J Surg 1990;160(3):306-312.
169. McDermott FT, Hughes ES, Pihl E, Johnson WR, Price AB. Local recurrence after potentially curative resection for rectal cancer in a series of 1008 patients. Br J Surg 1985;72(1):34-37.
170. Sticca RP, Rodriguez-Bigas M, Penetrante RB, Petrelli NJ. Curative resection for stage I rectal cancer: natural history, prognostic factors, and recurrence patterns. Cancer Invest 1996; 14(5):491-497.
171. Wilson SM, Beahrs OH. The curative treatment of carcinoma of the sigmoid, rectosigmoid, and rectum. Ann Surg 1976; 183(5):556-565.
172. Bailey HR, Huval WV, Max E, Smith KW, Butts DR, Zamora LF. Local excision of carcinoma of the rectum for cure. Surgery (St. Louis) 1992;111(5):555-561.
173. Chakravarti A, Compton CC, Shellito PC, et al. Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. Ann Surg 1999; 230(1):49-54.
174. Ota DM, Skibber J, Rich T. M.D. Anderson Cancer Center experience with local excision and multimodality therapy for rectal cancer. Surg Clin N Am 1992;1:147-152.
175. Steele GD, Jr., Herndon JE, Bleday R, et al. Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol 1999;6(5):433-441.
176. Baron PL, Enker WE, Zakowski MF, Urmacher C. Immediate vs. salvage resection after local treatment for early rectal cancer. Dis Colon Rectum 1995;38(2):177-181.
177. Crile G Jr, Turnbull RB Jr. The role of electrocoagulation in the treatment of carcinoma of the rectum. Surg Gynecol Obstet 1972;135(3):391-396.
178. Papillon J. Endocavity irradiation of early rectal cancers for cure: a series of 123 cases. Proc R Soc Med 1973;66(12):1179-1181.
179. Hull TL, Lavery IC, Saxton JP. Endocavitary irradiation. An option in select patients with rectal cancer. Dis Colon Rectum 1994;37(12):1266-1270.
180. Myerson RJ, Ualz BJ, Kodner IJ, Fleshman J, Fri RD, Konefal JB. Endocavitary radiation therapy for rectal cancer: results with and without external beam. Endocurie Hypertherm Oncol 1989; 5:195-199.
181. Papillon J, Berard P. Endocavitary irradiation in the conservative treatment of adenocarcinoma of the low rectum. World J Surg 1992;16(3):451-457.
182. Birnbaum EH, Ogunbiyi OA, Gagliardi G, et al. Selection criteria for treatment of rectal cancer with combined external and endocavitary radiation. Dis Colon Rectum 1999;42(6):727-733; discussion 733-725.
183. Saclarides TJ. Transanal endoscopic microsurgery: a single surgeon's experience. Arch Surg 1998;133(6):595-598; discussion 598-599.
184. Buess G, Kipfmuller K, Hack D, Grussner R, Heintz A, Junginger T. Technique of transanal endoscopic microsurgery. Surg Endosc 1988;2(2):71-75.
185. Despretz J, Otmezguine Y, Grimard L, Calitchi E, Julien M. Conservative management of tumors of the rectum by radiotherapy and local excision. Dis Colon Rectum 1990;33(2):113-116.
186. Mohiuddin M, Marks G, Bannon J. High-dose preoperative radiation and full thickness local excision: a new option for selected T3 distal rectal cancers. Int J Radiat Oncol Biol Phys 1994;30(4):845-849.
187. Habr-Gama A, de Souza PM, Ribeiro U Jr, et al. Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum 1998;41(9):1087-1096.
188. Ruo L, Guillem JG, Minsky BD, Quan SH, Paty PB, Cohen AM. Preoperative radiation with or without chemotherapy and fullthickness transanal excision for selected T2 and T3 distal rectal cancers. Int J Colorectal Dis 2002;17(1):54-58.
189. Telford JJ, Saltzman JR, Kuntz KM, Syngal S. Impact of preoperative staging and chemoradiation versus postoperative chemoradiation on outcome in patients with rectal cancer: a decision analysis. J Natl Cancer Inst 2004;96(3):191-201.
190. Brown G, Davies S, Williams GT, et al. Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging? Br J Cancer 2004;91(1):23-29.
191. Harewood GC, Wiersema MJ. Cost-effectiveness of endoscopic ultrasonography in the evaluation of proximal rectal cancer. Am J Gastroenterol 2002;97(4):874-882.
192. Gavioli M, Bagni A, Piccagli I, Fundaro S, Natalini G. Usefulness of endorectal ultrasound after preoperative radiotherapy in rectal cancer: comparison between sonographic and histopathologic changes. Dis Colon Rectum 2000;43(8):1075-1083.
193. Vanagunas A, Lin DE, Stryker SJ. Accuracy of endoscopic ultrasound for restaging rectal cancer following neoadjuvant chemoradiation therapy. Am J Gastroenterol 2004;99(1):109-112.
194. Watanabe M, Sugimura K, Kuroda S, Okizuka H, Ishida T. CT assessment of postirradiation changes in the rectum and perirectal region. Clin Imaging 1995;19(3):182-187.
195. Sugimura K, Carrington BM, Quivey JM, Hricak H. Postirradiation changes in the pelvis: assessment with MR imaging. Radiology 1990;175(3):805-813.
196. Delrio P, Lastoria S, Avallone A, et al. [Early evaluation using PET-FDG of the efficiency of neoadjuvant radiochemotherapy treatment in locally advanced neoplasia of the lower rectum.] Tumori 2003;89(suppl 4):50-53.
197. Calvo FA, Domper M, Matute R, et al. 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 2004;58(2):528-535.
198. Guillem JG, Puig-La Calle J Jr, Akhurst T, et al. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis Colon Rectum 2000;43(1): 18-24.
199. Gunderson LL, Sargent DJ, Tepper JE, et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 2004;22(10):1785-1796.
200. Fernandez-Represa JA, Mayol JM, Garcia-Aguilar J. Total mesorectal excision for rectal cancer: the truth lies underneath. World J Surg 2004;28(2):113-116.
201. Martijn H, Voogd AC, van de Poll-Franse LV, Repelaer van Driel OJ, Rutten HJ, Coebergh JW. Improved survival of patients with rectal cancer since 1980: a population-based study. Eur J Cancer 2003;39(14):2073-2079.
202. Miles WE. A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon (1908). CA Cancer J Clin 1971;21(6):361-364.
203. Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 1988;80(1):21-29.
204. Pollett WG, Nicholls RJ. The relationship between the extent of distal clearance and survival and local recurrence rates after curative anterior resection for carcinoma of the rectum. Ann Surg 1983;198(2):159-163.
205. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986;2(8514):996-999.
206. Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994;344(8924):707-711.
207. Stocchi L, Nelson H, Sargent DJ, et al. Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol 2001;19(18): 3895-3902.
208. Quirke P, Scott N. The pathologist's role in the assessment of loal recurrence in rectal carcinoma. Surg Oncol Clin N Am 1992;1:1-17.
209. McAnena OJ, Heald RJ, Lockhart-Mummery HE. Operative and functional results of total mesorectal excision with ultralow anterior resection in the management of carcinoma of the lower one-third of the rectum. Surg Gynecol Obstet 1990; 170(6):517-521.
210. Nesbakken A, Nygaard K, Westerheim O, Lunde OC, Mala T. Audit of intraoperative and early postoperative complications after introduction of mesorectal excision for rectal cancer. Eur J Surg 2002;168(4):229-235.
211. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993;341(8843):457-460.
212. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.Arch Surg 1998;133(8):894-899.
213. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324(11):709-715.
214. Enker WE. Potency, cure, and local control in the operative treatment of rectal cancer. Arch Surg 1992;127(12):1396-1401; discussion 1402.
215. Moreira LF, Hizuta A, Iwagaki H, Tanaka N, Orita K. Lateral lymph node dissection for rectal carcinoma below the peritoneal reflection. Br J Surg 1994;81(2):293-296.
216. Hojo K, Koyama Y, Moriya Y. Lymphatic spread and its prognostic value in patients with rectal cancer. Am J Surg 1982; 144(3):350-354.
217. Glass RE, Ritchie JK, Thompson HR, Mann CV. The results of surgical treatment of cancer of the rectum by radical resection and extended abdomino-iliac lymphadenectomy. Br J Surg 1985; 72(8):599-601.
218. Dahlberg M, Glimelius B, Pahlman L. Changing strategy for rectal cancer is associated with improved outcome. Br J Surg 1999;86(3):379-384.
219. Porter GA, Soskolne CL, Yakimets WW, Newman SC. Surgeonrelated factors and outcome in rectal cancer. Ann Surg 1998; 227(2):157-167.
220. Holm T, Johansson H, Cedermark B, Ekelund G, Rutqvist LE. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg 1997;84(5):657-663.
221. Hermanek P, Wiebelt H, Staimmer D, Riedl S. Prognostic factors of rectum carcinoma-experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma. Tumori 1995;81(suppl 3):60-64.
222. Simons AJ, Ker R, Groshen S, et al. Variations in treatment of rectal cancer: the influence of hospital type and caseload. Dis Colon Rectum 1997;40(6):641-646.
223. Tiret E, Poupardin B, McNamara D, Dehni N, Parc R. Ultralow anterior resection with intersphincteric dissection-what is the limit of safe sphincter preservation? Colorectal Dis 2003; 5(5):454-457.
224. Lopez-Kostner F, Lavery IC, Hool GR, Rybicki LA, Fazio VW. Total mesorectal excision is not necessary for cancers of the upper rectum. Surgery (St. Louis) 1998;124(4):612-617; discussion 617-618.
225. Steichen FM, Ravitch MM. History of mechanical devices and instruments for suturing. Curr Probl Surg 1982;19(1):1-52.
226. Beart RW Jr, Kelly KA. Randomized prospective evaluation of the EEA stapler for colorectal anastomoses. Am J Surg 1981; 141(1):143-147.
227. Docherty JG, McGregor JR, Akyol AM, Murray GD, Galloway DJ. Comparison of manually constructed and stapled anastomoses in colorectal surgery. West of Scotland and Highland Anastomosis Study Group. Ann Surg 1995;221(2):176-184.
228. Cavaliere F, Pemberton JH, Cosimelli M, Fazio VW, Beart RW Jr. Coloanal anastomosis for rectal cancer. Long-term results at the Mayo and Cleveland Clinics. Dis Colon Rectum 1995; 38(8):807-812.
229. Lazorthes F, Fages P, Chiotasso P, Lemozy J, Bloom E. Resection of the rectum with construction of a colonic reservoir and colo-anal anastomosis for carcinoma of the rectum. Br J Surg 1986;73(2):136-138.
230. Sailer M, Fuchs KH, Fein M, Thiede A. Randomized clinical trial comparing quality of life after straight and pouch coloanal reconstruction. Br J Surg 2002;89(9):1108-1117.
231. Hallbook O, Pahlman L, Krog M, Wexner SD, Sjodahl R. Randomized comparison of straight and colonic J pouch anastomosis after low anterior resection. Ann Surg 1996;224(1):58-65.
232. Hida J, Yasutomi M, Maruyama T, et al. Indications for colonic J-pouch reconstruction after anterior resection for rectal cancer: determining the optimum level of anastomosis. Dis Colon Rectum 1998;41(5):558-563.
233. Drake DB, Pemberton JH, Beart RW Jr, Dozois RR, Wolff BG. Coloanal anastomosis in the management of benign and malignant rectal disease. Ann Surg 1987;206(5):600-605.
234. Minsky BD, Cohen AM, Enker WE, Sigurdson E. Phase I/II trial of pre-operative radiation therapy and coloanal anastomosis in distal invasive resectable rectal cancer. Int J Radiat Oncol Biol Phys 1992;23(2):387-392.
235. Minsky BD, Cohen AM, Enker WE, Paty P. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis. Int J Radiat Oncol Biol Phys 1995;31(3):553-559.
236. Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N Engl J Med 1985;312(23):1465- 1472.
237. Law WL, Chu KW. Impact of total mesorectal excision on the results of surgery of distal rectal cancer. Br J Surg 2001; 88(12):1607-1612.
238. Nissan A, Guillem JG, Paty PB, et al. Abdominoperineal resection for rectal cancer at a specialty center. Dis Colon Rectum 2001;44(1):27-35; discussion 35-36.
239. Paty PB, Enker WE, Cohen AM, Lauwers GY. Treatment of rectal cancer by low anterior resection with coloanal anastomosis. Ann Surg 1994;219(4):365-373.
240. Zaheer S, Pemberton JH, Farouk R, Dozois RR, Wolff BG, Ilstrup D. Surgical treatment of adenocarcinoma of the rectum. Ann Surg 1998;227(6):800-811.
241. Williams NS, Johnston D. Survival and recurrence after sphincter saving resection and abdominoperineal resection for carcinoma of the middle third of the rectum. Br J Surg 1984; 71(4):278-282.
242. Byfield JE, Calabro-Jones P, Klisak I, Kulhanian F. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X rays. Int J Radiat Oncol Biol Phys 1982;8(11):1923-1933.
243. Rich TA, Lokich JJ, Chaffey JT. A pilot study of protracted venous infusion of 5-fluorouracil and concomitant radiation therapy. J Clin Oncol 1985;3(3):402-406.
244. Wong CS, Stern H, Cummings BJ. Local excision and postoperative radiation therapy for rectal carcinoma. Int J Radiat Oncol Biol Phys 1993;25(4):669-675.
245. Ghanem AN, Perry KC. Malignant lymphoma as a complication of ureterosigmoidostomy. Br J Surg 1985;72(7):559-560.
246. Rider WD, Palmer JA, Mahoney LJ, Robertson CT. Preoperative irradiation in operable cancer of the rectum: report of the Toronto trial. Can J Surg 1977;20(4):335-338.
247. Roswit B, Higgins GA, Keehn RJ. Preoperative irradiation for carcinoma of the rectum and rectosigmoid colon: report of a National Veterans Administration randomized study. Cancer (Phila) 1975;35(6):1597-1602.
248. Gerard A, Buyse M, Nordlinger B, et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 1988;208(5):606-614.
249. Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer (Phila) 2001;92(4):896-902.
250. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997; 336(14):980-987.
251. Gerard JP. The use of radiotherapy for patients with low rectal cancer: an overview of the Lyon experience. Aust N Z J Surg 1994;64(7):457-463.
252. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8, 507 patients from 22 randomised trials. Lancet 2001; 358(9290):1291-1304.
253. Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Swedish Rectal Cancer Trial. Br J Surg 1993;80(10):1333-1336.
254. Frykholm GJ, Glimelius B, Pahlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993;36(6):564-572.
255. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345(9):638-646.
256. McCall JL, Cox MR, Wattchow DA. Analysis of local recurrence rates after surgery alone for rectal cancer. Int J Colorectal Dis 1995;10(3):126-132.
257. Hill GL, Rafique M. Extrafascial excision of the rectum for rectal cancer. Br J Surg 1998;85(6):809-812.
258. Marks G, Modiuddin M, Eitan A, Masoni L, Rakinic J. Highdose preoperative radiation and radical sphincter-preserving surgery for rectal cancer. Arch Surg 1991;126(12):1534-1540.
259. Gerard JP, Chapet O, Nemoz C, et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the Lyon R96-02 randomized trial. J Clin Oncol 2004;22(12):2404-2409.
260. Francois Y, Nemoz CJ, Baulieux J, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999;17(8):2396.
261. Moore HG, Gittleman AE, Minsky BD, et al. Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum 2004;47(3):279-286.
262. Cohen A, Minsky B, Schildky R. Cancer of the rectum. In: De Vita V, Hellman S, Rosenberg S (eds). Cancer: Principles and Practice of Oncology, 5th ed. Philadelphia: Lippincott Raven, 1997:1197-1234.
263. Meterissian S, Skibber J, Rich T, et al. Patterns of residual disease after preoperative chemoradiation in ultrasound T3 rectal carcinoma. Ann Surg Oncol 1994;1(2):111-116.
264. Janjan NA, Khoo VS, Abbruzzese J, et al. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M.D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 1999; 44(5):1027-1038.
265. Fleming J, Hunt K, Feig BW, et al. Primary tumor response to preoperative chemoradiation does not ensure the absence of regional lymph node metastases in patients with locally advanced rectal cancer. Presented at the 40th Meeting of the Society of Surgery of the Alimentary Tract, May 16-19, 1999, Orlando, F.L.
266. Stipa F, Zernecke A, Moore HG, et al. Residual mesorectal lymph node involvement following neoadjuvant combinedmodality therapy: rationale for radical resection? Ann Surg Oncol 2004;11(2):187-191.
267. Moore HG, Riedel E, Minsky BD, et al. Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol 2003;10(1):80-85.
268. Pigot F, Dernaoui M, Castinel A, Juguet F, Chaume JC, Faivre J. [Local excision with postoperative radiotherapy for T2 or T3 distal rectal cancer. Long-term results.] Ann Chir 2001; 126(7):639-643.
269. Kim CJ, Yeatman TJ, Coppola D, et al. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg 2001;234(3):352-358; discussion 358-359.
270. Minsky BD, Cohen AM, Kemeny N, et al. Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. J Clin Oncol 1992;10(8):1218-1224.
271. Crane CH, Skibber JM, Birnbaum EH, et al. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2003;57(1):84-89.
272. Janjan NA, Crane CN, Feig BW, et al. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2000;47(3):713-718.
273. Grann A, Minsky BD, Cohen AM, et al. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum 1997;40(5):515-522.
274. Rich TA, Skibber JM, Ajani JA, et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995;32(4):1025-1029.
275. Hyams DM, Mamounas EP, Petrelli N, et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R- 03. Dis Colon Rectum 1997;40(2):131-139.
276. Sauer R, Fietkau R, Wittekind C, et al. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Strahlenther Onkol 2001;177(4):173-181.
277. Sauer R. Adjuvant versus neoadjuvant combined modality treatment for locally advanced rectal cancer: first results of the German rectal cancer study (CAO/ARO/AIO-94). Int J Radiat Oncol Biol Phys 2003;57(suppl 2):S124-S125.
278. Sprangers MA, Taal BG, Aaronson NK, te Velde A. Quality of life in colorectal cancer. Stoma vs. nonstoma patients. Dis Colon Rectum 1995;38(4):361-369.
279. Kollmorgen CF, Meagher AP, Wolff BG, Pemberton JH, Martenson JA, Illstrup DM. The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg 1994;220(5):676-682.
280. Paty PB, Enker WE, Cohen AM, Minsky BD, Friedlander- Klar H. Long-term functional results of coloanal anastomosis for rectal cancer. Am J Surg 1994;167(1):90-94; discussion 94-95.
281. Weinstein GD, Rich TA, Shumate CR, et al. Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer. Int J Radiat Oncol Biol Phys 1995;32(1):197-204.
282. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52(1):23-47.
283. Bendell JC, Ryan DP. Current perspectives on anal cancer. Oncology (Huntingt) 2003;17(4):492-497, 502-503; discussion 503, 507-509
284. Klas JV, Rothenberger DA, Wong WD, Madoff RD. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer (Phila) 1999;85(8):1686-1693.
285. Olofinlade O, Adeonigbagbe O, Gualtieri N, et al. Anal carcinoma: a 15-year retrospective analysis. Scand J Gastroenterol 2000;35(11):1194-1199.
286. Moore HG, Guillem JG. Anal neoplasms. Surg Clin N Am 2002;82(6):1233- 1251.
287. Dujovny N, Quiros RM, Saclarides TJ. Anorectal anatomy and embryology. Surg Oncol Clin N Am 2004;13(2):277-293.
288. AJCC Cancer Staging Handbook, 6th ed. New York: Springer, 2002.
289. Peiffert D, Bey P, Pernot M, et al. Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications. Int J Radiat Oncol Biol Phys 1997;37(2):313-324.
290. Gerard JP, Ayzac L, Hun D, et al. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients. Radiother Oncol 1998;46(3):249-256.
291. Cummings BJ, Keane TJ, O'Sullivan B, Wong CS, Catton CN. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 1991;21(5):1115-1125.
292. Allal AS, Mermillod B, Roth AD, Marti MC, Kurtz JM. The impact of treatment factors on local control in T2-T3 anal carcinomas treated by radiotherapy with or without chemotherapy. Cancer (Phila) 15 1997;79(12):2329-2335.
293. Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996;14(9):2527-2539.
294. Perera D, Pathma-Nathan N, Rabbitt P, Hewett P, Rieger N. Sentinel node biopsy for squamous-cell carcinoma of the anus and anal margin. Dis Colon Rectum 2003;46(8):1027-1029; discussion 1030-1031.
295. Boman BM, Moertel CG, O'Connell MJ, et al. Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer (Phila) 1984;54(1):114-125.
296. Frost DB, Richards PC, Montague ED, Giacco GG, Martin RG. Epidermoid cancer of the anorectum. Cancer (Phila) 1984; 53(6):1285-1293.
297. Martenson JA Jr, Gunderson LL. External radiation therapy without chemotherapy in the management of anal cancer. Cancer (Phila) 1993;71(5):1736-1740.
298. Schlienger M, Krzisch C, Pene F, et al. Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases. Int J Radiat Oncol Biol Phys 1989;17(6): 1141-1151.
299. Dobrowsky W. Radiotherapy of epidermoid anal canal cancer. Br J Radiol 1989;62(733):53-58.
300. Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974;17(3):354-356.
301. Sischy B. The use of radiation therapy combined with chemotherapy in the management of squamous cell carcinoma of the anus and marginally resectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 1985;11(9):1587-1593.
302. Leichman L, Nigro N, Vaitkevicius VK, et al. Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy. Am J Med 1985;78(2):211-215.
303. Flam MS, John MJ, Mowry PA, Lovalvo LJ, Ramalho LD, Wade J. Definitive combined modality therapy of carcinoma of the anus. A report of 30 cases including results of salvage therapy in patients with residual disease. Dis Colon Rectum 1987; 30(7):495-502.
304. Grabenbauer GG, Schneider IH, Gall FP, Sauer R. Epidermoid carcinoma of the anal canal: treatment by combined radiation and chemotherapy. Radiother Oncol 1993;27(1):59-62.
305. Allal A, Kurtz JM, Pipard G, et al. Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison. Int J Radiat Oncol Biol Phys 1993;27(1):59-66.
306. Allal AS, Sprangers MA, Laurencet F, Reymond MA, Kurtz JM. Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy. Br J Cancer 1999;80(10):1588-1594.
307. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 1996; 348(9034):1049-1054.
308. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997;15(5):2040-2049.
309. Hung A, Crane C, Delclos M, et al. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index. Cancer (Phila) 2003;97(5):1195-1202.
310. Peiffert D, Giovannini M, Ducreux M, et al. High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study. Ann Oncol 2001;12(3):397-404.
311. Allal AS, Mermillod B, Roth AD, Marti MC, Kurtz JM. Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma. Int J Radiat Oncol Biol Phys 1997; 39(5):1099-1105.
312. Ellenhorn JD, Enker WE, Quan SH. Salvage abdominoperineal resection following combined chemotherapy and radiotherapy for epidermoid carcinoma of the anus. Ann Surg Oncol 1994; 1(2):105-110.
313. Nilsson PJ, Svensson C, Goldman S, Glimelius B. Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg 2002;89(11):1425-1429.
314. Longo WE, Vernava AM III, Wade TP, Coplin MA, Virgo KS, Johnson FE. Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy. Ann Surg 1994;220(1):40-49.
315. Pocard M, Tiret E, Nugent K, Dehni N, Parc R. Results of salvage abdominoperineal resection for anal cancer after radiotherapy. Dis Colon Rectum 1998;41(12):1488-1493.
316. Allal AS, Laurencet FM, Reymond MA, Kurtz JM, Marti MC. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment. Cancer (Phila) 1999;86(3):405-409.
317. van der Wal BC, Cleffken BI, Gulec B, Kaufman HS, Choti MA. Results of salvage abdominoperineal resection for recurrent anal carcinoma following combined chemoradiation therapy. J Gastrointest Surg 2001;5(4):383-387.
318. Smith AJ, Whelan P, Cummings BJ, Stern HS. Management of persistent or locally recurrent epidermoid cancer of the anal canal with abdominoperineal resection. Acta Oncol 2001; 40(1):34-36.
319. Tei TM, Stolzenburg T, Buntzen S, Laurberg S, Kjeldsen H. Use of transpelvic rectus abdominis musculocutaneous flap for anal cancer salvage surgery. Br J Surg 2003;90(5):575-580.
320. Stearns MW Jr, Urmacher C, Sternberg SS, Woodruff J, Attiyeh F. Cancer of the anal canal. Curr Probl Cancer 1980;4(12):1-44.
321. Papillon J, Montbarbon JF. Epidermoid carcinoma of the anal canal. A series of 276 cases. Dis Colon Rectum 1987;30(5): 324-333.
322. Gerard JP, Chapet O, Samiei F, et al. Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature. Cancer (Phila) 2001;92(1):77-84.
323. Greenall MJ, Magill GB, Quan SH, DeCosse JJ. Recurrent epidermoid cancer of the anus. Cancer (Phila) 1986;57(7): 1437-1441.
324. Humphrey LJ. Reducing leg edema after groin dissection. J Surg Oncol 1992;50(1):19.
325. Spratt J. Groin dissection. J Surg Oncol 2000;73(4):243-262.
326. Wood TF, Nora DT, Morton DL, et al. One hundred consecutive cases of sentinel lymph node mapping in early colorectal carcinoma: detection of missed micrometastases. J Gastrointest Surg 2002;6(3):322-329; discussion 229-330.
327. Trocha SD, Nora DT, Saha SS, Morton DL, Wiese D, Bilchik AJ. Combination probe and dye-directed lymphatic mapping detects micrometastases in early colorectal cancer. J Gastrointest Surg 2003;7(3):340-345; discussion 345-346.
328. Paramo JC, Summerall J, Poppiti R, Mesko TW. Validation of sentinel node mapping in patients with colon cancer. Ann Surg Oncol 2002;9(6):550-554.
329. Saha S, Bilchik A, Wiese D, et al. Ultrastaging of colorectal cancer by sentinel lymph node mapping technique-a multicenter trial. Ann Surg Oncol 2001;8(suppl 9):94S-98S.
330. Bilchik AJ, Saha S, Wiese D, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol 2001;19(4):1128-1136.
331. Joosten JJ, Strobbe LJ, Wauters CA, Pruszczynski M, Wobbes T, Ruers TJ. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 1999;86(4): 482-486.
332. Merrie AE, van Rij AM, Phillips LV, Rossaak JI, Yun K, McCall JL. Diagnostic use of the sentinel node in colon cancer. Dis Colon Rectum 2001;44(3):410-417.
333. Mellgren A, Sirivongs P, Rothenberger DA, Madoff RD, Garcia- Aguilar J. Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum 2000;43(8):1064-1071; discussion 1071-1074.
334. Balani A, Turoldo A, Braini A, Scaramucci M, Roseano M, Leggeri A. Local excision for rectal cancer. J Surg Oncol 2000; 74(2):158-162.
335. Garcia-Aguilar J, Mellgren A, Sirivongs P, Buie D, Madoff RD, Rothenberger DA. Local excision of rectal cancer without adjuvant therapy: a word of caution. Ann Surg 2000;231(3):345-351.
336. Nivatvongs S, Wolff BG. Technique of per anal excision for carcinoma of the low rectum. World J Surg 1992;16(3):447-450.
337. Willett CG, Tepper JE, Donnelly S, et al. Patterns of failure following local excision and local excision and postoperative radiation therapy for invasive rectal adenocarcinoma. J Clin Oncol 1989;7(8):1003-1008.
338. Biggers OR, Beart RW Jr, Ilstrup DM. Local excision of rectal cancer. Dis Colon Rectum 1986;29(6):374-377.
339. Bleday R, Breen E, Jessup JM, Burgess A, Sentovich SM, Steele G Jr. Prospective evaluation of local excision for small rectal cancers. Dis Colon Rectum 1997;40(4):388-392.
340. Valentini V, Morganti AG, De Santis M, et al. Local excision and external beam radiotherapy in early rectal cancer. Int J Radiat Oncol Biol Phys 1996;35(4):759-764.
341. Taylor RH, Hay JH, Larsson SN. Transanal local excision of selected low rectal cancers. Am J Surg 1998;175(5):360-363.
342. Panzironi G, De Vargas Macciucca M, Manganaro L, et al. Preoperative locoregional staging of rectal carcinoma: comparison of MR, TRUS and multislice CT. Personal experience. Radiol Med (Torino) 2004;107(4):344-355.
343. Shami VM, Parmar KS, Waxman I. Clinical impact of endoscopic ultrasound and endoscopic ultrasound-guided fine-needle aspiration in the management of rectal carcinoma. Dis Colon Rectum 2004;47(1):59-65.
344. Mathur P, Smith JJ, Ramsey C, et al. Comparison of CT and MRI in the pre-operative staging of rectal adenocarcinoma and prediction of circumferential resection margin involvement by MRI. Colorectal Dis 2003;5(5):396-401.
345. Fuchsjager MH, Maier AG, Schima W, et al. Comparison of transrectal sonography and double-contrast MR imaging when staging rectal cancer. AJR Am J Roentgenol 2003;181(2):421-427.
346. Nesbakken A, Lovig T, Lunde OC, Nygaard K. Staging of rectal carcinoma with transrectal ultrasonography. Scand J Surg 2003; 92(2):125-129.
347. Marusch F, Koch A, Schmidt U, et al. Routine use of transrectal ultrasound in rectal carcinoma: results of a prospective multicenter study. Endoscopy 2002;34(5):385-390.
348. Tobaruela E, Arribas D, Mortensen N. Is endosonography useful to select patients for endoscopic treatment of rectal cancer? Rev Esp Enferm Dig 1999;91(9):614-621.
349. Gagliardi G, Bayar S, Smith R, Salem RR. Preoperative staging of rectal cancer using magnetic resonance imaging with external phase-arrayed coils. Arch Surg 2002;137(4):447-451.
350. Kim NK, Kim MJ, Yun SH, Sohn SK, Min JS. Comparative study of transrectal ultrasonography, pelvic computerized tomography, and magnetic resonance imaging in preoperative staging of rectal cancer. Dis Colon Rectum 1999;42(6):770-775.
351. Garcia-Aguilar J, Pollack J, Lee SH, et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum 2002;45(1):10-15.
352. Gualdi GF, Casciani E, Guadalaxara A, d'Orta C, Polettini E, Pappalardo G. Local staging of rectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging: comparison with histologic findings. Dis Colon Rectum 2000;43(3): 338-345.
353. Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001;357(9255):497-504.
354. Hunerbein M, Totkas S, Ghadimi BM, Schlag PM. Preoperative evaluation of colorectal neoplasms by colonoscopic miniprobe ultrasonography. Ann Surg 2000;232(1):46-50.
355. Chiesura-Corona M, Muzzio PC, Giust G, Zuliani M, Pucciarelli S, Toppan P. Rectal cancer: CT local staging with histopathologic correlation. Abdom Imaging 2001;26(2):134-138.
356. Civelli EM, Gallino G, Mariani L, et al. Double-contrast barium enema and computerised tomography in the pre-operative evaluation of rectal carcinoma: are they still useful diagnostic procedures? Tumori 2000;86(5):389-392.
357. Akasu T, Kondo H, Moriya Y, et al. Endorectal ultrasonography and treatment of early stage rectal cancer. World J Surg 2000; 24(9):1061-1068.
358. Wolmark N, Rockette H, Fisher B, et al. The benefit of leucovorin- modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 1993;11(10):1879-1887.
359. Grinnell RS, Lane N. Benign and malignant adenomatous polyps and papillary adenomas of the colon and rectum: an analysis of 1, 856 tumors in 1, 335 patients. Surg Gynecol Obstet 1958; 106(6):519-538.
360. Waye JD, Frankel A. Treatment of early colon cancer. Gastroenterology 1974;66:796.
361. Wolff WI, Shinya H. Definitive treatment of "malignant" polyps of the colon. Ann Surg 1975;182(4):516-525.
362. Lock MR, Cairns DW, Ritchie JK, Lockhart-Mummery HE. The treatment of early colorectal cancer by local excision. Br J Surg 1978;65(5):346-349.
363. Kodaira S, Teramoto T, Ono S, Takizawa K, Katsumata T, Abe O. Lymph node metastases from carcinomas developing in pedunculated and semipedunculated colorectal adenomas. Aust N Z J Surg 1981;51(5):429-433.
364. Nivatvongs S. Management of polyps containing invasive carcinoma. In: Codner I, Fry R, Roe J (eds). Colon, Rectal, and Anal Surgery. St. Louis: CV Mosby; 1985:183.
365. Shatney CH, Lober PH, Gilbertson V, Sosin H. Management of focally malignant pedunculated adenomatous colorectal polyps. Dis Colon Rectum 1976;19(4):334-341.
366. Coutsoftides T, Lavery I, Benjamin SP, Sivak MV, Jr. Malignant polyps of the colon and rectum: a clinicopathologic study. Dis Colon Rectum 1979;22(2):82-86.
367. Colachio TA, Forde KA, Scantlebury VP. Endoscopic polypectomy: inadequate treatment for invasive colorectal carcinoma. Ann Surg 1981;194(6):704-707.